Numerous reports have found p53 aberrations to be a significantly negative prognostic factor in endometrial carcinomas in general, although how independent this significance is of the necessarily dependent variables of tumor histotype and tumor grade has been a subject of some debate [17–22]. The gene discussed is TP53; the disease is endometrial carcinoma.